Vitamin D deficiency is associated with reduced heart rate variability. Multiple 2025 studies confirm the connection—but the evidence for supplementation improving HRV is weaker than you might expect.
The Association Is Real
A 2025 Frontiers in Cardiovascular Medicine study of 250 hypertensive patients found those with vitamin D deficiency (<20 ng/mL) had significantly lower SDNN (p=0.04), SDANN (p=0.03), and Triangle Index (p=0.02) compared to those with adequate levels [1].
In elderly diabetic patients, a 2025 Frontiers in Endocrinology study found 25-(OH)D is a protective factor against HRV decline (OR=0.869). A serum level of 19.7 ng/mL predicted reduced HRV with 67% sensitivity and 77% specificity [2].
A 2022 study of 191 type 2 diabetics confirmed the gradient: the deficiency group showed significantly lower SDNN, RMSSD, pNN50, LF, HF, and elevated LF/HF ratio compared to the sufficient group (all p<0.05). Vitamin D levels correlated positively with RMSSD (p=0.002) [3].
Why It Matters
The mechanistic research suggests vitamin D affects HRV through:
Acetylcholine regulation - Vitamin D controls synthesis of acetylcholine (ACh), the neurotransmitter of parasympathetic activity. Deficient rats showed reduced ACh in cardiac tissue.
Potassium channel expression - Deficiency downregulates potassium channels (Kir, HERG, KVLQT1, MinK), disrupting cardiac autonomic homeostasis.
RAAS activation - The 2025 hypertensive study found deficiency associated with elevated aldosterone and aldosterone-to-renin ratio, indicating renin-angiotensin-aldosterone system activation.
The Supplementation Evidence Is Mixed
Here's where it gets complicated. While the association between low vitamin D and low HRV is consistent, the evidence that supplementation improves HRV is weaker:
Positive findings:
- An 8-week supplementation study in obese/overweight individuals showed increased parasympathetic index (PNSi) and R-R interval.
- IgA nephropathy patients showed more stable cardiac autonomic tone after oral vitamin D3 supplementation.
Null findings:
- In low cardiovascular risk populations, vitamin D status showed no association with HRV parameters.
- Healthy young adults without risk factors showed no relationship.
Who Might Benefit
The research suggests vitamin D's HRV effects are most relevant for:
Type 2 diabetics - Consistent association with cardiac autonomic neuropathy risk
Hypertensive patients - 2.5x higher coronary revascularization risk with deficiency
Elderly patients - Predictive value strongest in this population
Those with existing CV risk factors - Effects may be masked in healthy populations
Healthy, young, low-risk individuals probably won't see HRV improvements from supplementation.
Practical Takeaway
If you're tracking HRV and have risk factors (diabetes, hypertension, metabolic syndrome, older age), getting your vitamin D levels checked makes sense. The threshold appears to be around 20 ng/mL (50 nmol/L)—below this, autonomic function may be compromised.
But don't expect megadoses of vitamin D to boost your HRV if your levels are already adequate. The research supports correcting deficiency, not optimizing beyond sufficiency.
And remember—correlation doesn't mean causation. People with low vitamin D often have other factors (less outdoor time, less physical activity, poorer overall health) that independently affect HRV.
Sources
[1] Wang et al. (2025). Associations of vitamin D with coronary revascularization and heart rate variability in hypertensive patients. Frontiers in Cardiovascular Medicine.
[2] Frontiers in Endocrinology (2025). 25-hydroxyvitamin D as a predictor of reduced heart rate variability in elderly patients with diabetes mellitus.
[3] Chen et al. (2022). The association between vitamin D levels and heart rate variability in patients with type 2 diabetes mellitus. Medicine.